AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AlectorDenali TherapeuticsFate TherapeuticsBill.comHalozyme Therapeutics
SymbolNASDAQ:ALECNASDAQ:DNLINASDAQ:FATENASDAQ:RVMDNASDAQ:HALO
Price Information
Current Price$32.90$28.41$31.97$33.58$24.27
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.01.21.51.82.2
Analysis Score1.52.43.44.43.4
Community Score2.52.53.03.22.6
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.01.03.0
Earnings & Valuation Score0.00.00.00.61.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$29.67$29.80$35.88$45.67$28.63
% Upside from Price Target-9.83% downside4.89% upside12.24% upside35.99% upside17.94% upside
Trade Information
Market Cap$2.62 billion$2.94 billion$2.46 billion$1.81 billion$3.30 billion
Beta1.011.881.77N/A1.74
Average Volume580,124615,9881,081,184315,6751,710,010
Sales & Book Value
Annual Revenue$21.22 million$26.68 million$10.68 millionN/A$195.99 million
Price / Sales122.53112.48232.57N/A16.82
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.83 per share$4.11 per share$3.24 per shareN/A$0.63 per share
Price / Book11.636.919.87N/A38.52
Profitability
Net Income$-105,390,000.00$-197,610,000.00$-98,150,000.00N/A$-72,240,000.00
EPS($1.71)($2.07)($1.44)N/A($0.50)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/A15.56
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-556.70%-825.96%-1,059.44%N/A-48.75%
Return on Equity (ROE)-48.29%-46.48%-52.08%N/A-48.92%
Return on Assets (ROA)-25.78%-34.60%-38.45%N/A-17.36%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%0.12%0.34%N/A6.66%
Current Ratio7.75%12.70%8.36%N/A11.14%
Quick Ratio7.75%12.70%8.36%N/A10.15%
Ownership Information
Institutional Ownership Percentage59.48%75.03%97.33%79.33%95.37%
Insider Ownership Percentage13.90%21.20%21.41%N/A2.60%
Miscellaneous
Employees91179104N/A281
Shares Outstanding79.03 million105.63 million77.69 million59.01 million135.82 million
Next Earnings Date8/10/2020 (Estimated)8/4/2020 (Estimated)8/4/2020 (Estimated)8/13/2020 (Estimated)8/4/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.